Amedisys, Inc. (NASDAQ:AMED) Shares Purchased by Wolverine Asset Management LLC

Wolverine Asset Management LLC increased its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 13.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 35,181 shares of the health services provider’s stock after purchasing an additional 4,299 shares during the period. Wolverine Asset Management LLC’s holdings in Amedisys were worth $3,344,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Exchange Traded Concepts LLC purchased a new position in Amedisys during the third quarter worth about $609,000. Commonwealth Equity Services LLC boosted its stake in shares of Amedisys by 2.9% in the third quarter. Commonwealth Equity Services LLC now owns 3,896 shares of the health services provider’s stock valued at $364,000 after purchasing an additional 110 shares during the period. Xponance Inc. boosted its stake in shares of Amedisys by 3.2% in the third quarter. Xponance Inc. now owns 4,076 shares of the health services provider’s stock valued at $381,000 after purchasing an additional 125 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Amedisys by 12.7% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,893 shares of the health services provider’s stock valued at $550,000 after purchasing an additional 663 shares during the period. Finally, ING Groep NV boosted its stake in shares of Amedisys by 257.4% in the third quarter. ING Groep NV now owns 189,800 shares of the health services provider’s stock valued at $17,727,000 after purchasing an additional 136,700 shares during the period. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on AMED shares. StockNews.com started coverage on shares of Amedisys in a research note on Monday, April 8th. They issued a “buy” rating for the company. Royal Bank of Canada raised their target price on shares of Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, March 25th. Finally, Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a report on Tuesday, March 26th. Seven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Amedisys currently has a consensus rating of “Hold” and an average target price of $97.50.

Amedisys Stock Down 0.1 %

NASDAQ:AMED traded down $0.11 during mid-day trading on Wednesday, hitting $91.05. The stock had a trading volume of 35,364 shares, compared to its average volume of 277,807. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.32. Amedisys, Inc. has a twelve month low of $73.10 and a twelve month high of $96.44. The stock has a 50-day simple moving average of $92.67 and a two-hundred day simple moving average of $93.39. The company has a market capitalization of $2.97 billion, a PE ratio of -294.06, a PEG ratio of 4.29 and a beta of 0.86.

Amedisys (NASDAQ:AMED) last announced its earnings results on Wednesday, February 21st. The health services provider reported $0.94 EPS for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.10). The business had revenue of $570.79 million during the quarter, compared to analyst estimates of $566.85 million. Amedisys had a negative net margin of 0.44% and a positive return on equity of 12.76%. The business’s revenue was up 1.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.16 earnings per share. On average, equities research analysts anticipate that Amedisys, Inc. will post 4.54 EPS for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.